Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Interim Management Statement

26 Jul 2010 07:00

RNS Number : 8697P
Creston PLC
26 July 2010
 



 

 

 

Press Release 26 July 2010

 

Creston plc

Interim Management Statement 

 

Creston plc ("Creston" or the "Group") (LSE: CRE), the Insight and Communications Group, announces its interim management statement for the period 1 April 2010 to 25 July 2010.

 

Trading

 

As announced in Creston's preliminary statement on 28 June 2010 the Group has started the new financial year positively. The continuing Group post the disposal of DLKW Group on 14 July 2010 has delivered like-for-like revenue growth of 11 per cent for the 3 month period to 30 June 2010. This compares favourably to the 6 per cent like-for-like revenue decline reported for the comparable quarter of 2009 and the 4 per cent revenue decline reported for the financial year ending 31 March 2010.

 

The positive start to the new financial year has been driven by a number of new business wins including Astellas, Guinness, GSK, Shire Pharmaceuticals, Smith & Nephew, Sony Professional Services and ViiV.

 

Balance Sheet

 

Following the disposal of DLKW the Group had a positive cash balance of over £1 million on 14 July 2010 and access to an unutilised bank facility of £25 million.

 

Outlook

As a result of the first quarter growth in like-for-like revenue, demonstrating the quality and resilience of the continuing Group, and the momentum in new business wins, trading continues in line with management's and market expectations.

 

For further information, please contact:

 

Creston plc

020 7930 9757

Don Elgie, Chief Executive

 

Barrie Brien, COO/CFO

 

www.creston.com

 

 

 

M:Communications

 

Elly Williamson

020 7920 2339

 

 

 

 

About Creston plc

 

§ Creston is an Insight and Communications company for the 21st century. It offers clients more seamless access to the most innovative marketing insights and communications services to help grow their brands in a rapidly-changing consumer world. Our companies draw upon the collective knowledge, expertise and services from across-the-Group, so that their clients receive the best advice and achieve the best results no matter what the medium. By working together, whether on research or as full-scale marketing partners, our companies continuously innovate to make more things possible for their clients and people.

 

§ Creston companies offer a range of marketing services, such as advertising, direct and digital marketing, market research, public relations and healthcare marketing to a broad range of blue-chip clients including: Amazon, AstraZeneca, Aviva, Bayer, BMW, BT, Burger King, Canon, COI Communications, Danone, Diageo, First Direct, GlaxoSmithKline, HTCJaguar, Kimberly-Clark, Land Rover, Lexus, Lloyds Black Horse, Nissan, O2, Pfizer, RocheDiagnostics, Royal Mail, Sainsbury's, Tesco, Thorpe Park, Toshiba, Toyota, T-Mobile, Tropicana, Unilever, Vodafone and Walkers.

 

§ Creston's share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEASXDALLEEFF
Date   Source Headline
10th Dec 20257:00 amRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20252:09 pmRNSHolding(s) in Company
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20254:04 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20254:47 pmRNSHolding(s) in Company
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20252:43 pmRNSHolding(s) in Company
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20255:42 pmRNSHolding(s) in Company
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSDirectorate Change
5th Nov 20257:00 amRNSTrading update for Q3 2025
4th Nov 20257:00 amRNSAppointment of Chief Underwriting Officer
22nd Oct 20257:00 amRNSNotice of Trading Update for Q3 2025
12th Aug 20254:31 pmRNSHolding(s) in Company
6th Aug 20254:50 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSInterim results for the six months ended 30/06/25
17th Jul 20257:00 amRNSNotice of Interim Results for 2025
16th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
3rd Jun 20257:00 amRNSTransaction in Own Shares
27th May 20257:00 amRNSHolding(s) in Company
27th May 20257:00 amRNSTransaction in Own Shares
23rd May 20257:00 amRNSTransaction in Own Shares
22nd May 20257:00 amRNSTransaction in Own Shares
20th May 20254:53 pmRNSTransaction in Own Shares
20th May 20257:00 amRNSTransaction in Own Shares
19th May 20257:00 amRNS$50 million Share Buyback Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.